• Citer

Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

par Bourhis, Jean;Rivera, Fernando;Mesia, Ricard;Awada, Ahmad ;Geoffrois, Lionel;Borel, Christian;Humblet, Yves;Lopez-Pousa, J J;Hitt, Ricardo;Vega Villegas, M Eugenia;Duck, Lionel;Rosine, Dominique;Amellal, Nadia;Schueler, Armin;Harstrick, Andreas
Référence Journal of clinical oncology, 24, 18, page (2866-2872)
Publication Publié, 2006-06

Article révisé par les pairs

• Détails
• Contenu

Titre:	Phase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Auteur:	Bourhis, Jean; Rivera, Fernando; Mesia, Ricard; Awada, Ahmad; Geoffrois, Lionel; Borel, Christian; Humblet, Yves; Lopez-Pousa, J J; Hitt, Ricardo; Vega Villegas, M Eugenia; Duck, Lionel; Rosine, Dominique; Amellal, Nadia; Schueler, Armin; Harstrick, Andreas
Informations sur la publication:	Journal of clinical oncology, 24, 18, page (2866-2872)
Statut de publication:	Publié, 2006-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Antibodies, Monoclonal -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Carboplatin -- administration & dosage
	Carcinoma, Squamous Cell -- drug therapy
	Carcinoma, Squamous Cell -- secondary
	Cisplatin -- administration & dosage
	Female
	Fluorouracil -- administration & dosage
	Head and Neck Neoplasms -- drug therapy
	Head and Neck Neoplasms -- pathology
	Humans
	Male
	Middle Aged
	Neoplasm Recurrence, Local -- drug therapy
	Survival Analysis
Note générale:	Clinical Trial, Phase I
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2005.04.3547
	info:pii/JCO.2005.04.3547
	info:scp/33745519512
	info:pmid/16717293